ArticleEuropean journal of clinical pharmacology2020

A comparison between the assessments of progression-free survival by local investigators versus blinded independent central reviews in phase III oncology trials.

Cinzia Dello Russo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.